Greenbrook TMS Inc. (NASDAQ:GBNH) Expected to Announce Quarterly Sales of $11.70 Million – Defense World

Wall Street analysts expect that Greenbrook TMS Inc. (NASDAQ:GBNH Get Rating) will report sales of $11.70 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Greenbrook TMSs earnings, with the lowest sales estimate coming in at $10.70 million and the highest estimate coming in at $12.70 million. Greenbrook TMS reported sales of $11.31 million during the same quarter last year, which indicates a positive year over year growth rate of 3.4%. The firm is scheduled to issue its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Greenbrook TMS will report full-year sales of $67.33 million for the current fiscal year, with estimates ranging from $57.30 million to $82.00 million. For the next fiscal year, analysts anticipate that the business will report sales of $83.60 million, with estimates ranging from $63.40 million to $115.00 million. Zacks Investment Researchs sales averages are an average based on a survey of research analysts that cover Greenbrook TMS.

Greenbrook TMS (NASDAQ:GBNH Get Rating) last released its quarterly earnings results on Wednesday, March 30th. The company reported ($0.34) EPS for the quarter, beating analysts consensus estimates of ($0.38) by $0.04. Greenbrook TMS had a negative net margin of 47.42% and a negative return on equity of 189.28%. During the same quarter last year, the company posted ($0.60) earnings per share.

Several large investors have recently modified their holdings of GBNH. Masters Capital Management LLC raised its stake in Greenbrook TMS by 55.6% in the fourth quarter. Masters Capital Management LLC now owns 700,000 shares of the companys stock worth $2,954,000 after buying an additional 250,000 shares in the last quarter. Virtu Financial LLC bought a new position in Greenbrook TMS in the fourth quarter worth about $288,000. AdvisorShares Investments LLC raised its stake in Greenbrook TMS by 365.5% in the fourth quarter. AdvisorShares Investments LLC now owns 64,214 shares of the companys stock worth $281,000 after buying an additional 50,418 shares in the last quarter. Royce & Associates LP raised its stake in Greenbrook TMS by 8.0% in the fourth quarter. Royce & Associates LP now owns 223,500 shares of the companys stock worth $977,000 after buying an additional 16,598 shares in the last quarter. Finally, Rockefeller Capital Management L.P. bought a new position in Greenbrook TMS in the third quarter worth about $109,000. 16.73% of the stock is owned by hedge funds and other institutional investors.

GBNH opened at $2.72 on Friday. The company has a fifty day moving average price of $3.18 and a 200-day moving average price of $4.68. The firm has a market capitalization of $48.42 million and a P/E ratio of -1.70. The company has a debt-to-equity ratio of 2.26, a current ratio of 1.34 and a quick ratio of 1.34. Greenbrook TMS has a one year low of $2.70 and a one year high of $13.89.

About Greenbrook TMS (Get Rating)

Greenbrook TMS Inc, together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.